Deutsch English Français

Contact

EP1263472

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1263472

EP1263472 - MODIFICATION OF BIOPOLYMERS FOR IMPROVED DRUG DELIVERY [Right-click to bookmark this link]
Status	The application has been refused Status updated on 13.03.2015 Database last updated on 29.03.2025
Most recent event Tooltip	13.03.2015	Refusal of application	published on 15.04.2015 [2015/16]
Applicant(s)	For all designated states GENZYME CORPORATION One Kendall Square Cambridge Massachusetts 02139-1562 / US
	[N/P]
Former [2002/50]	For all designated states GENZYME CORPORATION One Kendall Square Cambridge, Massachusetts 02139-1562 / US
Inventor(s)	01 / CALIAS, Pericles 39 Swains Pond Avenue Melrose, MA 02176 / US
	02 / MILLER, Robert, J. 500 E. Falls Blvd 5131 Quincy, MA 02169 / US
	[2007/32]
Former [2003/02]	01 / CALIAS, Pericles 39 Swains Pond Avenue Melrose, MA 02176 / US
	02 / MILLER, Robert, J. 500 E. Falls Blvd #5131 Quincy, MA 02169 / US
Former [2002/50]	01 / CALIAS, Pericles 39 Swains Pond Avenue Melrose, MA 02176 / US
	02 / MILLER, Robert, J. 59 Fairway Drive Halifax, MA 02338 / US
Representative(s)	Wallace, Sheila Jane, et al Marks & Clerk LLP 15 Fetter Lane London EC4A 1BW / GB
	[N/P]
Former [2002/50]	Wallace, Sheila Jane, et al Lloyd Wise Commonwealth House, 1-19 New Oxford Street London WC1A 1LW / GB
Application number, filing date	01910775.4	15.02.2001
	[2002/50]
	WO2001US04925
Priority number, date	US20000182558P	15.02.2000 Original published format: US 182558 P
	US20000211508P	14.06.2000 Original published format: US 211508 P
	[2002/50]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0160412
	Date:	23.08.2001
	Language:	EN
	[2001/34]
	Type:	A2 Application without search report
	No.:	EP1263472
	Date:	11.12.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.08.2001 takes the place of the publication of the European patent application.
	[2002/50]
Search report(s)	International search report - published on:	EP	24.01.2002
Classification	IPC:	A61K47/48	[2002/50]
	CPC:	A61K47/61 (EP); A61P1/16 (EP); A61P35/00 (EP); A61P7/00 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/50]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	MODIFIZIERUNG VON BIOPOLYMEREN FÜR DIE VERBESSERTE ABGABE VON ARZNEIMITTELN	[2002/50]
	English:	MODIFICATION OF BIOPOLYMERS FOR IMPROVED DRUG DELIVERY	[2002/50]
	French:	MODIFICATION DE BIOPOLYMERES POUR ADMINISTRATION AMELIOREE DE MEDICAMENTS	[2002/50]
Entry into regional phase	16.09.2002	National basic fee paid
	16.09.2002	Designation fee(s) paid
	16.09.2002	Examination fee paid
Examination procedure	07.09.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	16.09.2002	Amendment by applicant (claims and/or description)
	16.09.2002	Examination requested [2002/50]
	01.03.2007	Despatch of a communication from the examining division (Time limit: M06)
	11.09.2007	Reply to a communication from the examining division
	15.04.2008	Despatch of a communication from the examining division (Time limit: M06)
	23.10.2008	Reply to a communication from the examining division
	03.09.2010	Date of oral proceedings
	20.09.2010	Despatch of communication that the application is refused, reason: substantive examination [2015/16]
	20.09.2010	Minutes of oral proceedings despatched
	09.10.2014	Application refused, date of legal effect [2015/16]
Appeal following examination	29.11.2010	Appeal received No. T0569/11
	31.01.2011	Statement of grounds filed
	09.10.2014	Result of appeal procedure: appeal of the applicant was rejected
	09.10.2014	Date of oral proceedings
	22.10.2014	Minutes of oral proceedings despatched
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.03.2007
Fees paid	Renewal fee
	25.02.2003	Renewal fee patent year 03
	23.02.2004	Renewal fee patent year 04
	22.02.2005	Renewal fee patent year 05
	27.02.2006	Renewal fee patent year 06
	27.02.2007	Renewal fee patent year 07
	25.02.2008	Renewal fee patent year 08
	26.02.2009	Renewal fee patent year 09
	24.02.2010	Renewal fee patent year 10
	23.02.2011	Renewal fee patent year 11
	15.02.2012	Renewal fee patent year 12
	12.02.2013	Renewal fee patent year 13
	12.02.2014	Renewal fee patent year 14
	11.02.2015	Renewal fee patent year 15
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO9114696 (GILEAD SCIENCES INC [US]) [X] 1-54 * page 5, line 15 - page 6, line 11 * * page 14, line 16 - page 20, line 24 * * page 22, line 11 - page 24, line 7 * * page 26, line 20 - page 31, line 29 * * example -; claim - *;
		[X]US5169934 (CLARK BRIAN R [US], et al) [X] 1-4,9,15,24,45,46,51,54 * the whole document *;
		[X]WO9308842 (SOMATOGEN INC [US]) [X] 1-4,9,15,20,21,45,51,52 * page 37, line 23 - page 43, line 20 * * example -; claim - *;
		[X]WO9852614 (UNIV LELAND STANFORD JUNIOR [US], et al) [X] 1-54 * page 3, line 5 - page 5, line 20 * * page 6, line 20 - page 28, line 3 * * example -; claim - *;
		[X]WO9966063 (ISIS PHARMACEUTICALS INC [US], et al) [X] 1-5,9,15,20,21,45 * page 1, line 10 - page 47, line 3 *;
		[X] - DADLEY-MOORE D L ET AL, "Synthetic peptide antigens induce antibodies to Taenia ovis oncospheres", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (199903), vol. 17, no. 11-12, ISSN 0264-410X, pages 1506 - 1515, XP004158279 [X] 1-4,9,15,45,51 * paragraphs [02.4] , [02.5] * DOI: http://dx.doi.org/10.1016/S0264-410X(98)00366-1
		[X] - GEORGE Y. WU AND CATHERINE H. WU, "Receptor-mediated in Vitro Gene Transformation by a Soluble DNA Carrier System", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19870405), vol. 262, no. 10, pages 4429 - 4432, XP002176177 [X] 1-4,9,15,45,47 * the whole document *
	Examination	WO9114696
		US5639473
		- Luo & Prestwich (1999) Bioconj. Chem. 10, 755-763.
		- Li et al. (1998) Cancer Res. 58, 2404-2409.
		- Prestwich et al. (1998) J. Control Rel. 53, 93-103.
		- Wang et al. (1998) Bioconj. Chem. 9, 749-757.
	by applicant	WO9114696
		US5169934
		WO9308842
		US5354853
		US5451661
		WO9852614
		US5902795
		US5932552
		- A. BURNKOP-SCHNURCH ET AL., J. CONTROLLED RELEASE, (2000), vol. 66, page 39
		- YI LUO; GLENN D. PRESTWICH, BIOCONJUGATE CHEM., (1999), vol. 10, pages 755 - 763
		- CHUN LI ET AL., CANCER RESEARCH, (19980601), vol. 58, pages 2404 - 2409
		- GLENN D. PRESTWICH ET AL., JOURNAL OF CONTROLLED RELEASE, (1998), vol. 53, pages 93 - 103
		- LAIXIN WANG ET AL., BIOCONJUGATE CHEM., (1998), vol. 9, pages 749 - 757
		US19990430857

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p